MediWound Ltd. is a biopharmaceutical company. The Company focuses on developing, manufacturing and commercializing therapeutics products in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders and other indications. The Company's product, NexoBrid, is indicated for the removal of dead or damaged tissue, known as eschar, in adults with deep partial- and full-thickness thermal burns, also referred to as severe burns. The Company sells NexoBrid in Europe and Israel. NexoBrid is a topically-applied product that removes eschar in four hours without harming the surrounding healthy tissues. Its product, EscharEx, is a topical biological drug, which is being developed for debridement of chronic and other hard-to-heal wounds. NexoBrid and EscharEx are based on its proteolytic enzyme technology. The Company is also developing an injectable product based on its proteolytic enzyme technology for connective tissue pathologies and indications.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Biopharmaceuticals
- Sub-Industry: N/A
- Symbol: NASDAQ:MDWD
- CUSIP: N/A
- Web: www.mediwound.com
Capitalization:- Market Cap: $109.77 million
- Outstanding Shares: 21,954,000
Average Prices:- 50 Day Moving Avg: $6.30
- 200 Day Moving Avg: $6.53
- 52 Week Range: $4.25 - $8.58
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -7.94
- P/E Growth: -0.07
Sales & Book Value:- Annual Revenue: $2.17 million
- Price / Sales: 50.59
- Book Value: ($0.02) per share
- Price / Book: -250.00
Profitability:- EBIDTA: ($16,180,000.00)
- Net Margins: -752.78%
- Return on Equity: -326.32%
- Return on Assets: -48.65%
Debt:- Current Ratio: 5.94%
- Quick Ratio: 5.68%
Misc:- Average Volume: 48,506 shs.
- Beta: 0.11
- Short Ratio: 2.97
Frequently Asked Questions for MediWound (NASDAQ:MDWD)
What is MediWound's stock symbol?
MediWound trades on the NASDAQ under the ticker symbol "MDWD."
How were MediWound's earnings last quarter?
MediWound Ltd. (NASDAQ:MDWD) posted its quarterly earnings results on Thursday, August, 3rd. The company reported ($0.20) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.19) by $0.01. The firm had revenue of $0.69 million for the quarter, compared to the consensus estimate of $0.69 million. MediWound had a negative return on equity of 326.32% and a negative net margin of 752.78%. The business's revenue was up 93.8% compared to the same quarter last year. During the same period last year, the company posted ($0.34) earnings per share. View MediWound's Earnings History.
When will MediWound make its next earnings announcement?
Where is MediWound's stock going? Where will MediWound's stock price be in 2017?
4 brokers have issued 12-month target prices for MediWound's shares. Their predictions range from $10.00 to $11.00. On average, they anticipate MediWound's share price to reach $10.33 in the next twelve months. View Analyst Ratings for MediWound.
Who are some of MediWound's key competitors?
Some companies that are related to MediWound include Mereo BioPharma Group PLC (MPH), Kadmon Holdings (KDMN), Kamada (KMDA), Vericel Corporation (VCEL), Peregrine Pharmaceuticals (PPHM), VIVUS (VVUS), Alimera Sciences (ALIM), Opiant Pharmaceuticals (OPNT), Cardiome Pharma Corporation (CRME), KalVista Pharmaceuticals (KALV), Chiasma (CHMA), Cesca Therapeutics (KOOL), Tokai Pharmaceuticals (NVUS), Ocera Therapeutics (OCRX), Sonoma Pharmaceuticals (SNOA), Catalyst Biosciences (CBIO), Onconova Therapeutics (ONTX) and Argos Therapeutics (ARGS).
Who are MediWound's key executives?
MediWound's management team includes the folowing people:
- Aharon Yaari, Chairman of the Board
- Cal Cohen, Chief Executive Officer
- Sharon Malka, Chief Financial Officer
- Eilon Asculai, Vice President, Research & Development
- Lior Rosenberg, Chief Medical Officer
- Vickie R. Driver, Director
- Stephen T. Wills CPA, Director
Who owns MediWound stock?
MediWound's stock is owned by many different of retail and institutional investors. Top institutional investors include Migdal Insurance & Financial Holdings Ltd. (9.24%),
YELIN LAPIDOT HOLDINGS MANAGEMENT LTD.
(5.70%), California Public Employees Retirement System (0.91%), Broadfin Capital LLC (0.80%), Wells Fargo & Company MN (0.30%) and Oppenheimer & Co. Inc. (0.11%). View Institutional Ownership Trends for MediWound.
Who sold MediWound stock? Who is selling MediWound stock?
Who bought MediWound stock? Who is buying MediWound stock?
How do I buy MediWound stock?
Shares of MediWound can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is MediWound's stock price today?
One share of MediWound stock can currently be purchased for approximately $5.00.
MarketBeat Community Rating for MediWound (NASDAQ MDWD)MarketBeat's community ratings are surveys of what our community members think about MediWound and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for MediWound (NASDAQ:MDWD) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 4 Buy Ratings |
| Consensus Rating: | Buy (Score: 3.00) |
| Consensus Price Target: | $10.33 (106.67% upside) |
Analysts' Ratings History for MediWound (NASDAQ:MDWD)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 9/18/2017 | Oppenheimer Holdings, Inc. | Reiterated Rating | Buy | $10.00 | Low |  |
| 8/25/2017 | Jefferies Group LLC | Set Price Target | Buy | $10.00 | High | |
| 6/26/2017 | SunTrust Banks, Inc. | Reiterated Rating | Buy | | Low | |
| 5/25/2017 | Aegis | Reiterated Rating | Buy | $11.00 | Low | |
| 8/17/2016 | Wells Fargo & Company | Initiated Coverage | Outperform | $14.00 | N/A | |
| 4/23/2016 | Brean Capital | Reiterated Rating | Buy | | N/A | |
(Data available from 9/22/2015 forward)
Earnings History for MediWound (NASDAQ:MDWD)Earnings History by Quarter for MediWound (NASDAQ MDWD)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 11/13/2017 | | | | | | | | |
| 8/3/2017 | 6/30/2017 | ($0.19) | ($0.20) | $0.69 million | $0.69 million | View | Listen | |
| 5/8/2017 | 3/31/2017 | ($0.17) | ($0.20) | $0.56 million | $0.54 million | View | Listen | |
| 2/21/2017 | 12/31/2016 | ($0.25) | ($0.09) | $0.73 million | $0.43 million | View | Listen | |
| 11/14/2016 | Q316 | ($0.26) | ($0.26) | $0.61 million | $0.52 million | View | N/A | |
| 7/28/2016 | Q216 | ($0.23) | ($0.34) | $0.45 million | $3.36 million | View | Listen | |
| 4/21/2016 | Q116 | ($0.24) | ($0.17) | $0.28 million | $0.25 million | View | Listen | |
| 1/25/2016 | Q415 | ($0.23) | ($0.36) | $0.40 million | $0.27 million | View | Listen | |
| 10/27/2015 | Q315 | ($0.31) | ($0.17) | $0.47 million | $334.00 million | View | Listen | |
| 8/3/2015 | Q215 | ($0.26) | ($0.19) | $0.22 million | $0.17 million | View | Listen | |
| 5/4/2015 | Q1 2015 | ($0.30) | ($0.28) | $0.18 million | $0.07 million | View | Listen | |
| 2/12/2015 | Q4 | ($0.26) | ($0.33) | $0.10 million | $0.12 million | View | Listen | |
| 11/5/2014 | Q3 | ($0.25) | ($0.24) | $0.31 million | $0.05 million | View | Listen | |
| 7/31/2014 | Q2 | ($0.15) | ($0.28) | $0.19 million | $0.89 million | View | Listen | |
| 5/2/2014 | Q1 2014 | ($0.11) | ($0.05) | | $0.05 million | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for MediWound (NASDAQ:MDWD)2017 EPS Consensus Estimate: ($0.72)
2018 EPS Consensus Estimate: ($0.48)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 3 | ($0.19) | ($0.10) | ($0.16) |
| Q2 2017 | 3 | ($0.21) | ($0.13) | ($0.18) |
| Q3 2017 | 3 | ($0.20) | ($0.19) | ($0.20) |
| Q4 2017 | 3 | ($0.21) | ($0.17) | ($0.19) |
| Q1 2018 | 1 | ($0.11) | ($0.11) | ($0.11) |
| Q2 2018 | 1 | ($0.15) | ($0.15) | ($0.15) |
| Q3 2018 | 1 | ($0.12) | ($0.12) | ($0.12) |
| Q4 2018 | 1 | ($0.10) | ($0.10) | ($0.10) |
(Data provided by Zacks Investment Research)
Dividend History for MediWound (NASDAQ:MDWD)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for MediWound (NASDAQ:MDWD)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for MediWound (NASDAQ:MDWD)
Latest Headlines for MediWound (NASDAQ:MDWD)
| Source: |
|
| Date | Headline |
|---|
 | Research Analysts Offer Predictions for MediWound Ltd.'s FY2017 Earnings (MDWD)
www.americanbankingnews.com - September 22 at 7:22 AM |
| Research Analysts Set Expectations for MediWound Ltd.'s Q1 2018 Earnings (MDWD)
www.americanbankingnews.com - September 20 at 8:58 AM |
 | MediWound Secondary Capitalizes on 2017 Success
247wallst.com - September 20 at 6:13 AM |
 | MediWound (MDWD) Announces Common Share Offering
www.streetinsider.com - September 20 at 6:13 AM |
 | All You Need To Know About MediWound Ltd’s (MDWD) Risks
finance.yahoo.com - September 20 at 6:13 AM |
| MediWound Ltd. to Post Q3 2018 Earnings of ($0.12) Per Share, Oppenheimer Holdings Forecasts (MDWD)
www.americanbankingnews.com - September 19 at 10:12 AM |
 | MediWound Ltd. Announces Pricing of $22 Million Public Offering of Ordinary Shares
feeds.benzinga.com - September 19 at 7:43 AM |
| MediWound Ltd. :MDWD-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017
finance.yahoo.com - September 18 at 9:14 PM |
| MediWound Ltd. Announces Public Offering of Ordinary Shares
finance.yahoo.com - September 18 at 9:14 PM |
| MediWound Ltd. (MDWD) Receives "Buy" Rating from Oppenheimer Holdings, Inc.
www.americanbankingnews.com - September 18 at 8:58 PM |
| Zacks: Brokerages Expect MediWound Ltd. (MDWD) Will Post Quarterly Sales of $740,000.00
www.americanbankingnews.com - September 17 at 3:16 AM |
| Head to Head Review: MediWound (MDWD) & Sonoma Pharmaceuticals (SNOA)
www.americanbankingnews.com - September 14 at 4:18 AM |
| MediWound’s NexoBrid® Wins Best Poster Presentation Award at the 17th European Burns Association Congress
finance.yahoo.com - September 12 at 1:04 AM |
| MediWound’s NexoBrid® Highlighted in 43 Presentations at the 17th European Burns Association Congress
finance.yahoo.com - September 7 at 1:39 AM |
| Contrasting MediWound (MDWD) and Tokai Pharmaceuticals (NVUS)
www.americanbankingnews.com - September 6 at 6:26 PM |
| MediWound (MDWD) Completes Second Cohort of EscharEx Phase 2 Study
www.streetinsider.com - September 3 at 7:40 PM |
| MediWound Successfully Completes Second Cohort of EscharEx® Phase 2 Study
finance.yahoo.com - September 2 at 6:11 AM |
| MediWound Ltd. (MDWD) Expected to Announce Quarterly Sales of $740,000.00
www.americanbankingnews.com - August 30 at 11:28 AM |
| -$0.19 Earnings Per Share Expected for MediWound Ltd. (MDWD) This Quarter
www.americanbankingnews.com - August 28 at 6:16 AM |
| MediWound Ltd. (MDWD) PT Set at $10.00 by Jefferies Group LLC
www.americanbankingnews.com - August 26 at 11:02 AM |
| $740,000.00 in Sales Expected for MediWound Ltd. (NASDAQ:MDWD) This Quarter
www.americanbankingnews.com - August 11 at 9:28 AM |
| MediWound Ltd. to Post FY2017 Earnings of ($0.80) Per Share, SunTrust Banks Forecasts (NASDAQ:MDWD)
www.americanbankingnews.com - August 10 at 10:42 AM |
| Head to Head Contrast: Alimera Sciences (ALIM) & MediWound (NASDAQ:MDWD)
www.americanbankingnews.com - August 10 at 12:32 AM |
| -$0.20 EPS Expected for MediWound Ltd. (NASDAQ:MDWD) This Quarter
www.americanbankingnews.com - August 9 at 8:24 PM |
| Jefferies Group Weighs in on MediWound Ltd.'s Q3 2017 Earnings (NASDAQ:MDWD)
www.americanbankingnews.com - August 7 at 7:40 AM |
| Edited Transcript of MDWD earnings conference call or presentation 3-Aug-17 12:30pm GMT
finance.yahoo.com - August 5 at 2:39 AM |
| MediWound Reports Second Quarter 2017 Financial Results
finance.yahoo.com - August 4 at 1:35 AM |
| MediWound Ltd. (MDWD) Posts Earnings Results, Misses Estimates By $0.01 EPS
www.americanbankingnews.com - August 3 at 4:50 PM |
| MediWound Ltd. (MDWD) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - July 21 at 11:19 AM |
| MediWound Ltd. (NASDAQ:MDWD) Expected to Announce Earnings of -$0.19 Per Share
www.americanbankingnews.com - July 20 at 5:21 PM |
| BARDA Upsizes Contract with MediWound and Exercises Option to Fund Further NexoBrid® Indications
finance.yahoo.com - July 20 at 12:59 AM |
| MediWound Ltd. (MDWD) Expected to Announce Quarterly Sales of $670,000.00
www.americanbankingnews.com - June 28 at 11:42 AM |
| Analysts Expect MediWound Ltd. (MDWD) to Post -$0.19 EPS
www.americanbankingnews.com - June 26 at 12:30 PM |
| MediWound Ltd. (MDWD) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - June 26 at 10:39 AM |
| MediWound's (MDWD) Buy Rating Reiterated at SunTrust Banks, Inc.
www.americanbankingnews.com - June 26 at 9:04 AM |
| BARDA Gives Notice of Intent to Exercise First Contract Option to Further Fund MediWound’s NexoBrid® Development
finance.yahoo.com - June 23 at 6:57 PM |
| Independent Study in Germany Shows NexoBrid® Reduces Average Burn Treatment Costs by nearly 30% Versus Standard of Care
finance.yahoo.com - June 16 at 7:26 PM |
| MediWound to Present at the Jefferies Global Healthcare Conference
finance.yahoo.com - June 5 at 9:26 AM |
| Poster Presentation Highlighting NexoBrid® Awarded “Best Poster” at the 52nd Congress of the Spanish Society of Aesthetic, Plastic and Reconstructive Surgery
finance.yahoo.com - June 2 at 7:54 PM |
| Mediwound Ltd (MDWD) Expected to Announce Quarterly Sales of $670,000.00
www.americanbankingnews.com - June 2 at 2:54 PM |
| Mediwound Ltd (MDWD) Given "Buy" Rating at Aegis
www.americanbankingnews.com - May 27 at 7:00 PM |
| MediWound Announces Changes to its Board of Directors
finance.yahoo.com - May 18 at 8:36 AM |
| Mediwound Ltd Expected to Post Q3 2017 Earnings of ($0.19) Per Share (MDWD)
www.americanbankingnews.com - May 11 at 9:54 AM |
| Q2 2017 EPS Estimates for Mediwound Ltd (MDWD) Boosted by Jefferies Group
www.americanbankingnews.com - May 11 at 8:14 AM |
| Mediwound Ltd to Post Q2 2017 Earnings of ($0.21) Per Share, Oppenheimer Holdings Forecasts (MDWD)
www.americanbankingnews.com - May 11 at 8:12 AM |
| MediWound Ltd. :MDWD-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017
finance.yahoo.com - May 10 at 12:35 PM |
| Mediwound Ltd (MDWD) PT Set at $10.00 by Oppenheimer Holdings Inc.
www.americanbankingnews.com - May 9 at 2:34 PM |
| Edited Transcript of MDWD earnings conference call or presentation 8-May-17 12:30pm GMT
finance.yahoo.com - May 9 at 11:52 AM |
| Mediwound Ltd (MDWD) Posts Quarterly Earnings Results, Misses Estimates By $0.03 EPS
www.americanbankingnews.com - May 8 at 8:38 PM |
| MediWound Reports First Quarter 2017 Financial Results
finance.yahoo.com - May 8 at 12:32 PM |
MediWound (MDWD) Chart for Friday, September, 22, 2017
